Skip to main content

Wall Street Analysts Are Bullish on Top Communication Services Picks

Tipranks - Fri Mar 6, 2:14AM CST

There’s a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on Nexxen International (NEXNResearch Report) and StubHub Holdings Incorporation Class A (STUBResearch Report) with bullish sentiments.

Claim 70% Off TipRanks Premium

Nexxen International (NEXN)

RBC Capital analyst Mark Fielding maintained a Buy rating on Nexxen International yesterday and set a price target of $10.00. The company’s shares closed last Wednesday at $6.68.

According to TipRanks.com, Fielding is ranked #400 out of 12134 analysts.

Currently, the analyst consensus on Nexxen International is a Moderate Buy with an average price target of $8.75, representing a 36.3% upside. In a report released yesterday, Needham also assigned a Buy rating to the stock with a $7.50 price target.

See the top stocks recommended by analysts >>

StubHub Holdings Incorporation Class A (STUB)

TD Cowen analyst John Blackledge maintained a Buy rating on StubHub Holdings Incorporation Class A yesterday and set a price target of $25.00. The company’s shares closed last Wednesday at $10.17, close to its 52-week low of $8.30.

According to TipRanks.com, Blackledge is a 5-star analyst with an average return of 9.2% and a 51.0% success rate. Blackledge covers the Technology sector, focusing on stocks such as Uber Technologies, Grindr, and Lyft. ;'>

Currently, the analyst consensus on StubHub Holdings Incorporation Class A is a Moderate Buy with an average price target of $17.33.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.